Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SysmexTSE:6869 +1.82%82 EV-to-EBITDA is 11.02 as of Aug. 30, 2026, which is 44% below its 10-year median of 19.52. GuruFocus rates TSE:6869 with a GF Score™ of 82/100 and a GF Value™ of 円2,912.52 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 520 Medical Devices & Instruments companies, Sysmex ranks better than 62.31% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sysmex's enterprise value is 円1,186,847 Mil.
Sysmex's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was 円107,713 Mil. Therefore, Sysmex's EV-to-EBITDA for today is 11.02.
The historical rank and industry rank for Sysmex's EV-to-EBITDA or its related term are showing as below:
TSE:6869'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.07 Med: 19.52 Max: 38.23
Current: 11.02
During the past 13 years, the highest EV-to-EBITDA of Sysmex was 38.23. The lowest was 7.07. And the median was 19.52.
TSE:6869's EV-to-EBITDA is ranked better than 62.31% of 520
companies
in the Medical Devices & Instruments industry
Industry Median: 14.66
vs TSE:6869: 11.02
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2026-08-30), Sysmex's stock price is 円1955.00.
Sysmex's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was 円63.760. Therefore, Sysmex's PE Ratio (TTM) for today is 30.66.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sysmex's share price for today is 円1955.00.
Sysmex's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円63.760.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Sysmex's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6869 vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, Sysmex's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sysmex EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Sysmex's EV-to-EBITDA falls into.
Sysmex's current Enterprise Value is 円1,186,847 Mil.
Sysmex's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円107,713 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sysmex (TSE:6869) has a EV-to-EBITDA of 11.02 as of Aug. 30, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Sysmex. This is 44% below median its historical median of 19.52. Over the past decade, Sysmex's EV-to-EBITDA has ranged from 7.07 to 38.23. According to the industry distribution chart, Sysmex ranks #196 out of 520 companies in the Medical Devices & Instruments industry, placing it in the top 37.7%.
Is Sysmex's EV-to-EBITDA too high?
Sysmex's current EV-to-EBITDA of 11.02 is 44% below median its 10-year median of 19.52. Over the past 10 years, this metric has ranged from a low of 7.07 to a high of 38.23. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.66. Sysmex's value of 11.02 is 24.8% below this industry median. Based on the distribution chart, Sysmex ranks #196 out of 520 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sysmex has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sysmex's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sysmex ranks #196 out of 520 companies for EV-to-EBITDA. This puts Sysmex in the upper half of its industry. The industry median EV-to-EBITDA is 14.66. Sysmex's value of 11.02 is 24.8% below this benchmark. Historically, Sysmex's own EV-to-EBITDA has ranged from 7.07 to 38.23 over the past decade. While the company's 10-year median is 19.52 vs. the industry median of 14.66, Sysmex has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.66, based on 520 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sysmex's current EV-to-EBITDA of 11.02 is 24.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Sysmex. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sysmex's current EV-to-EBITDA is 11.02, which is 44% below median its own 10-year median of 19.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sysmex stock overvalued right now?
Based on GuruFocus' analysis, Sysmex (TSE:6869) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,912.52, compared to a current price of 円1,955.00 — trading 32.9% below its estimated fair value. The current EV-to-EBITDA is 11.02, which is 44% below median its 10-year median of 19.52 and 24.8% below the Medical Devices & Instruments industry median of 14.66. Sysmex's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Sysmex (TSE:6869), the current EV-to-EBITDA is 11.02 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sysmex (TSE:6869) Overvalued in 2026?
Based on GuruFocus' analysis, Sysmex stock appears to be undervalued.
The current stock price of 円1,955.00 is trading 32.9% below its estimated GF Value™ of 円2,912.52.
GuruFocus considers Sysmex to be Significantly Undervalued.
Key valuation signals for TSE:6869:
EV-to-EBITDA: 11.02 (44% below median its 10-year median of 19.52)
GF Value™: 円2,912.52 vs. price of 円1,955.00 (32.9% below fair value)
Industry Position: 24.8% below the Medical Devices & Instruments median (#196 of 520)
No single metric tells the full story. See the TSE:6869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sysmex Corp manufactures and sells laboratory testing equipment and reagents. It conducts product development, manufacturing, sales, and service activities in domestic markets, while certain products are also developed, manufactured, and sold through its subsidiaries. The company operates through five reportable segments based on headquarters: Head Office Management, Americas Headquarters, EMEA Headquarters, China Headquarters, and AP Headquarters.
82GF Score
Get the complete analysis for TSE:6869
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6869 has been successfully added to your 
